Embracing Technology to Unlock New Growth in the Pharmaceutical Sector

Pharma Tech Outlook: Pharma Tech Magazine

Embracing Technology to Unlock New Growth in the Pharmaceutical Sector

Pharma Tech Outlook | Monday, December 19, 2022

Innovative technologies in the pharma industry are helping to drive growth, initiate new changes, and work towards the betterment of public health through better products and solutions.

FREMONT, CA: Recent challenges have prompted the pharma industry to adopt technological innovations. The latest technologies, such as AI, AR/VR, big data, and quantum computing, have found increasing acceptance from pharmaceutical companies to create personalised products, accelerate R&D efforts, and transform the experience for the users. As technological innovations and advancements continue, the pharma industry will further undergo rapid evolution and growth to cater to the rising healthcare demands worldwide by adopting new technologies and reshaping the sector.

Artificial intelligence (AI)

AI assists the pharmaceutical industry in accelerating drug discovery and manufacturing processes. Companies increasingly look at AI to optimise and automate the manufacturing process and design post-launch and effective marketing strategies. In addition, AI combined with machine learning (ML) helps pharmaceutical companies analyse the profiles of individuals and compare the efficacy of drugs and demand. Consequently, manufacturers create improved drugs and medicine by understanding their effectiveness in specific individuals.

Big Data and Analytics

The cost associated with R&D is a primary hindrance in the launch of new medicines or drugs. As a result, many times, there is not adequate manufacturing and dispatching of medicines. However, by using big data and analytics, researchers can reduce exploration cycles, making the discovery and development of new drugs faster. Furthermore, big data can be used to determine the side effects of a new drug beforehand, which consequently reduces the time required for clinical trials.

Single-use Use Processes

Many pharmaceutical companies are adopting this technology as part of their manufacturing processes. With SUT-powered bioreactors, pharmaceutical companies can develop reliable products without sterilising containers. With less maintenance, firms are already utilising SUT to report quick turnaround and manufacturing times and simplified operations. Equipment running on SUT is easy to set up. It takes a few hours as compared to stainless setups which can take at least a couple of days. In addition, maintaining the system is straightforward without any need for annual cleaning, sterilisation validations and minimum monitoring.


A major challenge remaining for the pharmaceutical industry is clinical testing. Pharma companies test the safety and efficacy of a drug on live subjects with the help of bioprinting. Using techniques like 3D printing, and bioprinting can create imitations of human organs and tissues. This technology conjugates cells with growth factors and various biomaterials to create a mesh-like structure. These organs replace live subjects in clinical trials and form tissues and micro-organs reacting in the same way as a human body to new drugs and medicines.

The pandemic has evoked the pharma industry to rethink its processes and make them work more efficiently. Innovative technologies are providing pharmaceutical firms with the much-needed assistance they need to spur growth, bring new developments, and strive toward improving public health through better products and solutions.

Weekly Brief

Read Also